Immediate-type hypersensitivity and other clinical reactions in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum sporozoites
- 1 December 2002
- Vol. 21 (3-4) , 269-280
- https://doi.org/10.1016/s0264-410x(02)00468-1
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-119) and T helper epitopes of tetanus toxoidVaccine, 1999
- Preclinical evaluation of a synthetic Plasmodium falciparum MAP malaria vaccine in Aotus monkeys and micePublished by Elsevier ,1999
- Antigen-specific recall urticaria to a peptide-based vaccineJournal of Allergy and Clinical Immunology, 1999
- STINGING INSECT HYPERSENSITIVITY: A PRACTICE PARAMETERJournal of Allergy and Clinical Immunology, 1999
- Natural rubber latex skin testing reagents: Safety and diagnostic accuracy of nonammoniated latex, ammoniated latex, and latex rubber glove extractsJournal of Allergy and Clinical Immunology, 1996
- Plasmodium falciparum circumsporozoite vaccine immunogenicity and efficacy trial with natural challenge quantitation in an area of endemic human malaria of KenyaVaccine, 1996
- Recall urticaria: A case reportJournal of Allergy and Clinical Immunology, 1996
- Safety, immunogenicity and limited efficacy study of a recombinant Plasmodium falciparum circumsporozoite vaccine in Thai soldiersVaccine, 1994
- SPf66, a chemically synthesized subunit malaria vaccine, is safe and immunogenic in Tanzanians exposed to intense malaria transmissionVaccine, 1994
- Proceedings of the Task Force on guidelines for standardizing old and new technologies used for the diagnosis and treatment of allergic diseasesJournal of Allergy and Clinical Immunology, 1988